2026 NPPES data Ophthalmic Plastic and Reconstructive Surgery Physician NPI 1972764843 MD
Verify on CMS →

KATHERINE ZAMECKI-VEDDER, MD

Ophthalmic Plastic and Reconstructive Surgery Physician in DANBURY, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 526 beneficiaries · Ophthalmic Plastic and Reconstructive Surgery Physician avg: 624
Generic prescribing
41%
generic claims · 59% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
94.2464/100
▲ 11 pts above national avg 83.1 · [object Object]
Industry payments
$472.83
26 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

KATHERINE ZAMECKI-VEDDER, MD reported a CMS MIPS final score of 94.2464/100 — above the 83.1 national average — and filed 1,068 Medicare Part D claims in 2023.

94.2464/100
MIPS score · +11 vs avg
1K
Part D claims, 2023
41%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

KATHERINE ZAMECKI-VEDDER, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

94 Top 25% higher than 75% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

KATHERINE ZAMECKI-VEDDER, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about KATHERINE ZAMECKI-VEDDER, MD?

High performer (top quartile)

NPI registry status

Active

Issued 06/23/2008

NPI 1972764843

Primary specialty

Ophthalmic Plastic and Reconstructive Surgery Physician

Rare

291 US NPIs in this specialty

Medicare Part D claims

1,068 71% vs specialty avg

2023 prescription claims

Specialty avg: 624

MIPS final score

94.2464/100 11.1464% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Connecticut

How Ophthalmic Plastic and Reconstructive Surgery Physician compares to other specialties among Connecticut providers

Connecticut providers

Ophthalmic Plastic and Reconstructive Surgery Physician share within Connecticut

1. Ophthalmic Plastic and Reconstructive Surgery Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmic Plastic and Reconstructive Surgery Physician share within Connecticut

Medicare quality performance — MIPS

KATHERINE ZAMECKI-VEDDER, MD's 2023 MIPS final score plotted against the Ophthalmic Plastic and Reconstructive Surgery Physician national average

High performer (top quartile)
MIPS Final Score
94.2464/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Ophthalmic Plastic and Reconstructive Surgery Physician) — 94.2464/100 vs national avg 83.1

0%100%National avg83%94.2%
MIPS final score (Ophthalmic Plastic and Reconstructive Surgery Physician) — 94.2464/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

KATHERINE ZAMECKI-VEDDER, MD appears in the CMS NPPES registry as a Ophthalmic Plastic and Reconstructive Surgery Physician provider holding MD credentials at 69 SAND PIT RD, DANBURY, CT, 06810, with a listed phone of (203) 791-2020. NPI 1972764843 was issued on 06/23/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ZAMECKI-VEDDER most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,068 prescription claims written by this provider, covering 526 Medicare beneficiaries and totaling roughly $780K in drug spend, split 59% brand-name and 41% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 94.2464/100 for the 2023 performance year (Quality 78.2615), compared with the national average of 83.1.

Ophthalmic Plastic and Reconstructive Surgery Physician is a narrow specialty nationwide, with 291 enrolled providers across 46 states and an average of 624 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

69 SAND PIT RD
DANBURY, CT 06810

Provider Details

NPI 1972764843
Specialty Ophthalmic Plastic and Reconstructive Surgery Physician
Credentials MD
Gender Female
NPI Issued 06/23/2008

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

94.2464
Final Score
Avg: 83.1
78.2615
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where KATHERINE ZAMECKI-VEDDER, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CONNECTICUT EYE CONSULTANTS PC
DANBURY, CT

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for KATHERINE ZAMECKI-VEDDER, MD. Source: openpaymentsdata.cms.gov.

Total received

$473

Largest payer

SUN PHARMACEUTICAL INDUSTRIES INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Brand-heavy

KATHERINE ZAMECKI-VEDDER, MD — brand share 59.0%
Specialty average (est.)

59% brand-name claims vs 41% generic, on 1,068 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,068
Total Claims
$780K
Total Drug Cost
526
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,520
Total Day Supply
34,981
Brand vs Generic
59% brand / 41% generic
Brand Drug Cost
$755K
Generic Drug Cost
$24K
Antibiotic Claims
48

Patient Demographics

Average Patient Age
75.8 years
Avg HCC Risk Score
1.09
Gender Split
67% female / 33% male
Age Distribution
<65: 21, 65-74: 216, 75-84: 212, 85+: 77

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What KATHERINE ZAMECKI-VEDDER, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
262
Tobramycin-Dexamethasone
Tobramycin/Dexamethasone
109
Xiidra
Lifitegrast
94
Restasis
Cyclosporine
85
Erythromycin
Erythromycin Base
84
Loteprednol Etabonate
82
Prednisolone Acetate
63
Doxycycline Hyclate
37
Latanoprost
34
Cyclosporine
27

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmic Plastic and Reconstructive Surgery Physician Overview

How KATHERINE ZAMECKI-VEDDER, MD fits within the Ophthalmic Plastic and Reconstructive Surgery Physician landscape nationally.

291
Ophthalmic Plastic and Reconstructive Surgery Physician Providers in US
46
States with Ophthalmic Plastic and Reconstructive Surgery Physician
624
Avg Claims per Provider

KATHERINE ZAMECKI-VEDDER, MD's 1,068 claims are above the specialty average of 624.

Nearby Ophthalmic Plastic and Reconstructive Surgery Physician Providers in Connecticut

Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as ZAMECKI-VEDDER.

Compare Ophthalmic Plastic and Reconstructive Surgery Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is KATHERINE ZAMECKI-VEDDER, MD's specialty?
KATHERINE ZAMECKI-VEDDER, MD specializes in Ophthalmic Plastic and Reconstructive Surgery Physician and practices in DANBURY, Connecticut. Credentials: MD.
How much does KATHERINE ZAMECKI-VEDDER, MD prescribe under Medicare Part D?
In 2023, KATHERINE ZAMECKI-VEDDER, MD wrote 1,068 Medicare Part D claims totaling $780K in drug costs for 526 beneficiaries.
What is KATHERINE ZAMECKI-VEDDER, MD's Medicare quality score?
KATHERINE ZAMECKI-VEDDER, MD has a CMS MIPS Final Score of 94.2464/100 (Quality: 78.2615). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is KATHERINE ZAMECKI-VEDDER, MD located?
KATHERINE ZAMECKI-VEDDER, MD is located at 69 SAND PIT RD, DANBURY, CT, 06810. Phone: (203) 791-2020.
What is KATHERINE ZAMECKI-VEDDER, MD's NPI number?
KATHERINE ZAMECKI-VEDDER, MD's National Provider Identifier (NPI) is 1972764843, issued on 06/23/2008.
Does KATHERINE ZAMECKI-VEDDER, MD prescribe more brand-name or generic drugs?
KATHERINE ZAMECKI-VEDDER, MD's prescribing is 59% brand-name and 41% generic drugs by claim count, with $755K in brand drug costs.
How many Ophthalmic Plastic and Reconstructive Surgery Physician providers are there in the US?
There are 291 Ophthalmic Plastic and Reconstructive Surgery Physician providers across 46 states in the US. The average Ophthalmic Plastic and Reconstructive Surgery Physician provider writes 624 Medicare Part D claims per year.
What drugs does KATHERINE ZAMECKI-VEDDER, MD prescribe most often?
Based on 2023 Medicare Part D data, KATHERINE ZAMECKI-VEDDER, MD's most frequently prescribed drugs include Neomycin-Polymyxin-Dexameth, Tobramycin-Dexamethasone, Xiidra. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does KATHERINE ZAMECKI-VEDDER, MD accept Medicare?
KATHERINE ZAMECKI-VEDDER, MD appears in CMS Medicare data with 1,068 Part D claims and 526 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify KATHERINE ZAMECKI-VEDDER, MD's credentials?
KATHERINE ZAMECKI-VEDDER, MD's NPI is 1972764843 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology